Pinthus, J. 2015. Follicle stimulating hormone (FSH): A potential surrogate marker for androgen deprivation therapy (ADT) oncological and systemic effects. Canadian Urological Association Journal. 9, 3-4 (Apr. 2015), E226–7. DOI:https://doi.org/10.5489/cuaj.2874.